Financials
- Market Capitalization 43.73 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-21.14
Relación precio/flujo de caja
9 695.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 262 | ARGX argenx SE - American Depositary Shares | 1030.27 USD | -0.13% | +0.21% | +22.81% | +44.70% | 63.76 B USD | ||
| 291 | MRNA Moderna, Inc. - Common Stock | 143.38 USD | +2.17% | -6.07% | +161.02% | +499.16% | 57.24 B USD | ||
| 438 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 239.78 USD | -0.38% | +0.96% | +15.26% | -46.22% | 32.08 B USD | ||
| 485 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.41 USD | +0.92% | -0.07% | +5.77% | +64.81% | 27.42 B USD |